How to Buy Anaptysbio Stock
Anaptysbio Inc
AnaptysBio, Inc. , a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications.
Anaptysbio stock last closed at $26.34, up 1.23% from the previous day, and has increased 25.61% in one year. It has overperformed other stocks in the Biotechnology industry by 0.44 percentage points. Anaptysbio stock is currently +97.16% from its 52-week low of $13.36, and -4.22% from its 52-week high of $27.50.
At the moment, there are 26.76M ANAB shares outstanding. The market cap of ANAB is $704.94M. In the last 24 hours, 322,320 ANAB shares were traded.
How to Buy Anaptysbio Stock
Not sure how to invest in Anaptysbio stock? Here's how.
- Decide where to buy Anaptysbio stock: You need to choose an online brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you decide where to buy Anaptysbio stock.
- Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Choose your payment method and add your information.
- Analyze Anaptysbio stock: The Anaptysbio ticker symbol is ANAB. Is Anaptysbio stock a good investment? Should you buy shares of ANAB? How do ANAB's underlying business fundamentals look? Do top analysts think Anaptysbio is a good buy? Why has ANAB's stock price moved recently? (Hint: Our stock analysis website can help you decide if ANAB is a good stock to buy).
- Place your ANAB buy order: Decide if you will purchase ANAB shares at the current market price or use a limit order to purchase ANAB stock at a given price.
- Get the latest news on your ANAB position: Create a watchlist to key updates about your new investment in Anaptysbio shares.
Step 1: Decide where to buy Anaptysbio stock
You need a brokerage account in order to access the NASDAQ market and buy ANAB stock.
Our recommended brokerage: eToro
In our opinion, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world markets: From Tech to Healthcare, New York to Shanghai — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro now.
Open eToro AccountStep 2: Create a brokerage account
Now that you've picked your brokerage, it's time to fill out some personal info so you are able to invest in ANAB today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to create your new trading account.
- Submit your application by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have finished signing up on our top ranked stock app, you need to deposit funds:
Check out the walkthrough below if you need help transferring funds into your new brokerage account.
Step 4: Analyze Anaptysbio stock
After you have decided on the best place to buy Anaptysbio stock, it's important to evaluate their stock prior to buying, so you actually comprehend the risk and upside.
Anaptysbio shares at a glance
ANAB Fundamentals
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis quickly.
You can see all of the due diligence checks on ANAB's stock page.
How is ANAB stock valued?
Investors use many financial metrics, analyses, models, and charts to gauge ANAB's fair value.
Using relative valuations metrics:
- ANAB could be overvalued based on its P/B ratio of 8x, relative to Biotechnology industry P/B ratio of 5.99x
You can access additional valuation analysis on ANAB's stock here.
ANAB Financial Health Summary
Pros:
- ANAB has $390.90M in cash and short term investments. This is enough to cover its annual cash burn of $121.61M.
- ANAB has cash burn of 121607000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the ANAB balance sheet.
- There are more short-term assets than short-term liabilities on the ANAB balance sheet.
Cons:
- ANAB profit margin has gone up by 2.98 percentage points in the past year, but the company is still unprofitable.
- Total ANAB debt is higher than 5 years ago, relative to shareholder equity.
- ANAB has a relatively high debt to equity ratio of 4.14.
Is it a good time to buy ANAB stock, according to Wall Street analysts?
Out of 7 sell side analysts who give forecasts on ANAB, the consensus analyst rating on Anaptysbio is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent ANAB Analyst Forecasts
Yasmeen Rahimi, a top 5% analyst from Piper Sandler initiates coverage on ANAB with a strong buy rating and announces their ANAB price target of $80.00, on Feb 16, 2024.
David Nierengarten, a top 3% analyst from Wedbush reiterates ANAB with a hold rating and maintains their ANAB price target from $20.00 to $20.00, on Nov 29, 2023.
You can dig deeper into what analysts are forecasting on the Anaptysbio stock forecast page.
ANAB Technical Indicators
ANAB Earnings
Last year, ANAB revenue was $17.16M. In the last 5 year, ANAB's revenue has gone up by 27.97% per year. This was slower than the Biotechnology industry average of 29.57%.
Learn more about ANAB's earnings and revenue performance here.
What are ANAB executives and large shareholders up to?
Over the last 12 months, executives and large shareholders at ANAB have sold more shares than they have bought.
Daniel Faga, CEO of ANAB, was the latest ANAB insider to sell. They sold $7,504,725.60 worth of ANAB stock on Mar 26, 2024.
Learn more about who owns ANAB shares here.
Can I get consistent income from ANAB stock?
No, Anaptysbio doesn't provide an income stream by paying out dividends.
What others are saying about ANAB
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Place your ANAB buy order
There are two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly the best for newer investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a given price limit, use a limit order.
Press the Open Trade button and your broker will execute your order.
If you want additional help with buying stocks on eToro, click the how to video below:
Step 6: Get the latest news on your ANAB position
Now that you own some ANAB stock, you'll want to stay up-to-date on your new investment.
Put ANAB on a watchlist to get the latest updates about your ANAB stock.
ANAB Feed
How to Buy Stock in Anaptysbio
To reiterate, here are the 6 steps to buy stock in Anaptysbio:
- Decide where to buy Anaptysbio stock
- Create a brokerage account
- Deposit funds into your brokerage account
- Analyze Anaptysbio stock
- Place your ANAB buy order
- Get the latest news on your ANAB position
If you require a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get the latest scoop on your new investment in Anaptysbio, click the button below.
More Stock Buying Guides You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.